SYS-CON MEDIA Authors: Peter Silva, Unitiv Blog, RealWire News Distribution, Kevin Benedict, PR.com Newswire

News Feed Item

Biobanking Will Grow up to 30% by 2020, but Will Yours Grow With It?

LONDON, March 21, 2014 /PRNewswire/ --

Make sure you don't fall behind as Biobanking becomes increasingly important with the rise of biologic and personalize medicine by attending the Global Biobanking Forum in London from 6-8 May 2014. The forum will allow delegates to gain an understanding of cross-border regulatory requirements, pending EU regulations, consent, efficient storage, and tracking strategies to ensure quality.

Attracting leaders from industry, academia and institutions across the globe, the event will facilitate learning and development to maximise research opportunities. Additionally, co-located with the Compound and Sample Management, Biobanking brings all the key players under one roof to ensure you get the most out of your time.

Overcoming the challenges that stop efficient biobanking will enable you to:

  • Overcome data management challenges and how best to build an in house data system
  • Maximise sample utilisation and quality
  • Understand ethical and legal guidelines
  • Understand worldwide requirements and standardisation within biobanking
  • Collaborate and network between different institutes
  • Understand the technical advances between sample collection, assaying, storage and retrieval

With innovation and insights from industry-leading companies like UK Biobank, ISBER, GlaxoSmithKline, Pfizer and more, this is a can't miss opportunity!

Find the full program, event details and registration information about the Global Biobanking Forum 2014 on http://www.globalbiobanking.com, phone +44(0)20-7368-9300 or email [email protected].

Media contact: Mico Do Tanque, +44(0)20-736-1307, [email protected] or visit http://www.globalbiobanking.com.

Press are invited to attend this important industry forum, if you would like to receive a complimentary press pass, please email Mico Do Tanque [email protected].

 

SOURCE Pharma IQ

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.